Evidence map›Paper›PMID 31651100›Full record

ArticleJournal of cachexia, sarcopenia and muscle2020

Skeletal muscle mTORC1 regulates neuromuscular junction stability.

Martina Baraldo, Alessia Geremia, Marco Pirazzini, Leonardo Nogara, Francesca Solagna, Clara Türk, Hendrik Nolte, Vanina Romanello, Aram Megighian, Simona Boncompagni and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Muscle Disuse Atrophy.Advances in experimental medicine and biology · 2025
    Review
  16. Review
  17. Skeletal muscle dysfunction with advancing age.Clinical science (London, England : 1979) · 2024
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Martina BaraldoVenetian Institute of Molecular Medicine (VIMM), Padova, Italy.
Alessia GeremiaVenetian Institute of Molecular Medicine (VIMM), Padova, Italy.
Marco PirazziniDepartment of Biomedical Sciences, University of Padova, Padova, Italy.
Leonardo NogaraVenetian Institute of Molecular Medicine (VIMM), Padova, Italy.
Francesca SolagnaVenetian Institute of Molecular Medicine (VIMM), Padova, Italy.
Clara TürkInstitute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Hendrik NolteInstitute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Vanina RomanelloVenetian Institute of Molecular Medicine (VIMM), Padova, Italy.
Aram MegighianDepartment of Biomedical Sciences, University of Padova, Padova, Italy.
Simona BoncompagniCeSI-Met-Center for Research on Ageing and Translational Medicine and DNICS, Department of Neuroscience, Imaging and Clinical Sciences, University G. d' Annunzio, Chieti, Italy.
Marcus KrugerInstitute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Marco SandriVenetian Institute of Molecular Medicine (VIMM), Padova, Italy.
Bert BlaauwVenetian Institute of Molecular Medicine (VIMM), Padova, Italy.ORCID 0000-0002-4167-5106
University of Padua · ITCologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · DEUniversity of Chieti-Pescara · ITUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSkeletal muscle is a plastic tissue that can adapt to different stimuli. It is well established that Mammalian Target of Rapamycin Complex 1 (mTORC1) signalling is a key modulator in mediating increases in skeletal muscle mass and function. However, the role of mTORC1 signalling in adult skeletal muscle homeostasis is still not well defined.

methodsInducible, muscle-specific Raptor and mTOR k.o. mice were generated. Muscles at 1 and 7 months after deletion were analysed to assess muscle histology and muscle force.

resultsWe found no change in muscle size or contractile properties 1 month after deletion. Prolonging deletion of Raptor to 7 months, however, leads to a very marked phenotype characterized by weakness, muscle regeneration, mitochondrial dysfunction, and autophagy impairment. Unexpectedly, reduced mTOR signalling in muscle fibres is accompanied by the appearance of markers of fibre denervation, like the increased expression of the neural cell adhesion molecule (NCAM). Both muscle-specific deletion of mTOR or Raptor, or the use of rapamycin, was sufficient to induce 3-8% of NCAM-positive fibres (P < 0.01), muscle fibrillation, and neuromuscular junction (NMJ) fragmentation in 24% of examined fibres (P < 0.001). Mechanistically, reactivation of autophagy with the small peptide Tat-beclin1 is sufficient to prevent mitochondrial dysfunction and the appearance of NCAM-positive fibres in Raptor k.o. muscles.

conclusionsOur study shows that mTOR signalling in skeletal muscle fibres is critical for maintaining proper fibre innervation, preserving the NMJ structure in both the muscle fibre and the motor neuron. In addition, considering the beneficial effects of exercise in most pathologies affecting the NMJ, our findings suggest that part of these beneficial effects of exercise are through the well-established activation of mTORC1 in skeletal muscle during and after exercise.

Indexed as

AnimalsDisease Models, AnimalHumansMiceMice, KnockoutMuscle, SkeletalNeuromuscular JunctionTOR Serine-Threonine KinasesMTOR protein, humanTOR Serine-Threonine KinasesAutophagyMitochondrial dysfunctionmTORNMJ

Identifiers

PMID31651100
PMCPMC7015238
OpenAlexW2981581416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.